{
    "2021-11-01": [
        [
            {
                "time": "",
                "original_text": "价格创新低！或影响国谈",
                "features": {
                    "keywords": [
                        "价格",
                        "创新低",
                        "国谈"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "高燃回顾（2） | 立足时代前沿，擘画南京新医药与生命健康产业蓝图！",
                "features": {
                    "keywords": [
                        "南京",
                        "新医药",
                        "生命健康",
                        "产业蓝图"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "丁列明“10年100亿”，贝达药业能攻下千亿市值吗？",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "市值",
                        "目标"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "业绩更好的复星医药，为什么市值不足恒瑞医药一半？",
                "features": {
                    "keywords": [
                        "复星医药",
                        "恒瑞医药",
                        "市值",
                        "业绩"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-10-29",
                "original_text": "A股融资融券日报：两融余额减少52.62亿元（10月29日）",
                "features": {
                    "keywords": [
                        "两融余额",
                        "减少"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "市场资金"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-11-01",
                "original_text": "A股早报2021年11月1日星期一",
                "features": {
                    "keywords": [
                        "A股早报"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "市场整体"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "高瓴资本三季报A股持仓全扫描",
                "features": {
                    "keywords": [
                        "高瓴资本",
                        "三季报",
                        "持仓"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "多行业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "PD-1内卷之下 乐普生物还能靠普特利回血吗？| 睿见·新医药",
                "features": {
                    "keywords": [
                        "PD-1",
                        "乐普生物",
                        "内卷",
                        "普特利"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "Q3行情结束，医药板块进入估值切换长周【东吴医药朱国广团队】",
                "features": {
                    "keywords": [
                        "Q3行情",
                        "医药板块",
                        "估值切换"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}